Who
David Ross Smith
Interim CFO
Company insider
Files Form 4 as: Interim CFO, Fortrea Holdings; Corporate Executive VP & CFO, Charles River Laboratories International.
In numbers
- Trades disclosed
- 558
- Buys
- 0
- Sells
- 36
- Bought
- $0
- Sold
- $23.0M
- Companies
- 2
- Companies where not an officer
- 0
- First trade
- 12 Aug 2015
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,840 at $0.00 | filing |
| 3 Aug 2026filed 5 Aug 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —15,840 at $0.00 | filing |
| 20 Jul 2026filed 27 Jul 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —6,598 at $0.00 | filing |
| 20 Jul 2026filed 27 Jul 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —6,598 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —38,817 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $298K18,244 at $16.34 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —38,817 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —38,817 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —12,852 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —12,852 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —38,817 at $0.00 | filing |
| 10 Jun 2026filed 12 Jun 2026 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $298K18,244 at $16.34 | filing |
| 10 Jun 2025filed 12 Jun 2025 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —38,817 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —7,282 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —7,282 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $10K2,185 at $4.78 | filing |
| 18 Jul 2024filed 19 Jul 2024 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —6,354 at $0.00 | filing |
| 18 Jul 2024filed 19 Jul 2024 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code M | —6,354 at $0.00 | filing |
| 18 Jul 2024filed 19 Jul 2024 | FTRE Fortrea HoldingsDiagnostics & Labs | SEC FORM 4 Code F | $49K1,907 at $25.85 | filing |
| 14 May 2024filed 16 May 2024 | FTRE Fortrea Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —7,282 at $0.00 | filing |
The newest 500 lines are listed; the numbers count every line.
News
Head to Head Survey: Charles River Laboratories International (NYSE:CRL) & Sotera Health (NASDAQ:SHC)CRL · themarketsdaily.com · 9 Oct 2026Charles River Laboratories International (NYSE:CRL) EVP Sells 981 Shares of Company StockCRL · dailypolitical.com · 8 Oct 2026
0 headlines in the last 90 days name David Ross Smith; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.